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ABSTRACT. The food sector and health sector become more and more intertwined.
This raises many possibilities, but also questions. One of them is the question of what
the implication is for public trust in food and health issues. In this article, I argue
that the products on the interface between food and health entails some serious
questions of trust. Trust in food products and medical products is often based upon a
long history of rather clear patterns of mutual expectations, yet these expectations
are not similar in both sectors. As long as the food sector and health sector remain
distinct, these diﬀerences will not lead to problems of trust, yet when new products
are introduced, like functional foods or personalized dietary advices, trust can be
threatened. To prevent this, we need clarity with regard to what we can expect of
these new products and of whom to expect what in this situation. This requires
not only adequate information on operating procedures, but also a profound
debate on responsibilities and the explication and interpretation of moral values and
norms.
KEY WORDS: functional food, health, personalized dietary advice, trust, trust-
worthiness
1. THE IMPORTANCE OF TRUST FOR FOOD AND HEALTH
Milk that lowers your level of cholesterol, dietary advices based on genetic
knowledge, new scientiﬁc information on the link between a food product
and the occurrence of certain types of cancer. These are only some of the
many examples of the trend to use health knowledge in the development of
food and vice versa. The food and health sectors become more and more
intertwined. This raises many possibilities, but also questions. One of them
is the question of what the implication is for public trust in both food and
health products.
Trust is widely considered to be crucial for both the food sector (FAO,
2003) and the health sector (ONeill, 2002). First, both sectors have become
so complex that an individual cannot but rely on others. Neither as a
consumer nor as a patient is one able to assess all the risks and beneﬁts of a
product or treatment personally or to fully control any situation. Conse-
quently, we are all necessarily part of complex webs of trust relationships.
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With regard to health, we already have a very long tradition of relying on
experts, like physicians and pharmacists. However, it is also the case that it
has been many years since the average consumer was able to fully assess all
aspects of food consumption. This situation is not exclusive to food and
health, yet the importance of consuming food and good health for our daily
life leads us to a second reason of why trust is crucial for both sectors. We
value food and health highly. Thus, when we have to trust another with
regard to either one, or both of them, we have to entrust something highly
personal and valuable. This increases the impact of trust on our daily life
considerably. Finally, trust in the food sector and the domain of health is
colored by some recent aﬀairs and scandals. For instance, in a press release,
the Netherlands State Inspectorate of Health recently warned pharmacists
not to rely blindly on computerized medication systems because of some
serious medication errors that have been reported.1 Although all agents
probably want and aim to act in a trustworthy manner, the net result is that
the trust of some patients may be harmed. Another example is the MPA
scandal: In 2002, an illegal hormonal growth promoter, the synthetic pro-
gesterone MPA was found on Dutch pig farms. The scandal showed that
some agents within the agri-food sector deliberately abused the reliance and
trust of others. These examples are exceptions, but they aﬀect trust in the
sector.
Given the importance of trust for food and health, it seems reasonable to
state that when food aspects are introduced into the medical sector or vice
versa, the need for trust will not change. There are no indications that the
introduction of health related food products yields a situation in which
consumers no longer need to rely on other stakeholders. However, there are
indications that it can have a serious impact on trust. Trust in food and
health products is often based upon a long history of clear patterns and
routines. One knows what one may expect of another. The complicating
factor, however, is that the question of whom to expect what is answered
diﬀerently in the food sector than with regard to health issues. We expect
other things of a pharmacist than of the manager of a supermarket, even
though they both sell products that we directly consume. As long as both
sectors remain distinct, these diﬀerences will not lead to problems of trust.
Yet, when a functional food with a real health claim is sold in a super-
market, a reﬂection on mutual expectations is necessary. In order to elab-
orate on this claim, I ﬁrst sketch the current developments at the interface
between food and health in three ways. Next, I devote some analysis to what
we mean by trust. Based upon these two steps, I illustrate the implications of
1 Press release of August, 19, 2005, http://www.igz.nl/standaard.php?pagid = 427.
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the changing relationship between the food sector and health sector upon
the idea of trust.
2. FOOD AND HEALTH: THE CHANGING RELATIONSHIP
There are a wide range of products and developments that provide examples
of the changing relationship between food and health. These include a
speciﬁc health enhancing food product and rather broad scientiﬁc insights
into the link between certain substances and the occurrence of certain ail-
ments ﬁt within this development. Hence, it is helpful to diﬀerentiate the
development in order to trace its impact on trust. It is possible to distinguish
three forms of this development.
First, there is an increasing attention to the ‘‘health–diet’’ interaction.
The idea that food habits have a direct inﬂuence on ones health is certainly
not new, yet, as a result of two factors, the attention paid to this relation is
increasing. On the one hand, there is ongoing research that yields new in-
sights regarding the relation between food habits and the increase or de-
crease of the incidence of varies aliments, such as certain types of cancer and
diﬀerent forms of cardiovascular diseases. These scientiﬁc developments
have not only resulted in extensive literature on the impact of food habits on
health, but also in quite practical dietary advice. The daily recommended
200 g vegetables and 2 pieces of fruit is a good example of an eﬀective
guideline to decrease the risk of these ailments. On the other hand, there is
an increased attention to the ‘‘health–diet’’ interaction as a result of the
combination of enough safe food in the Western world and the unhealthy
food and lifestyle habits of many individuals. This has resulted in the
problem of obesity. In spite of the clear and practical general dietary ad-
vices, compliance rates are very low2 and even if they are followed, they are
often combined with all kinds of other unhealthy (food) habits. The ‘‘epi-
demic’’ character of obesity has alarmed diﬀerent groups and organizations
within society all over the World and has resulted in a strongly increased
awareness of the health aspect of food products and dietary patterns (WHO,
2000; Astrup, 2004).
In line with the increased attention to ‘‘health–diet’’ interactions, we can
distinguish a second development: the growing market for functional foods.
This is not one strictly deﬁned group of products, but is the term for a
variety of regular food products that have extra qualities that aim to en-
hance the consumers health. This development started in Japan as part of
the health care service in relation to the ageing population (Ichikawa, 1994).
2 Approximately 70–80 percent do not comply with this advice (Van Oers, 2002; p. 60, Kreijl
et al., 2004).
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Currently, it is a worldwide development that is very attractive from a
market perspective. In functional foods, two developments converge. First,
is the above-mentioned growing attention to ‘‘health–diet’’ interactions.
Second, is the development within the food sector of products that have
added value and consequently have better proﬁt margins. Since there is
enough safe food for everyone (in the Western world), the general policy of
the food sector has shifted from increasing production rates to more quality-
focused production (McInerney, 2002; Lang, 1999). The aim is no longer to
produce more products, but to search for product innovations that yield
products with added value. The link with health is an obvious one from that
perspective. The proﬁt margins and sales possibilities of health enhancing
products are much more promising than those of bulk goods. This has led to
the market introduction of various functional foods and to the planned
introduction of an even bigger number. Some of them are only partly related
to ones health, for instance performance improving soft drinks. Other
functional foods claim to have substantial health-improving eﬀects, like
margarines that lower elevated levels of blood cholesterol. The more these
food products have health-improving eﬀects the more the distinction be-
tween food and medicines becomes clouded. This raises several questions, as
we will see later on.
Finally, there is an increasing knowledge of the ‘‘gene–diet’’ interaction.
This is a combination of the development mentioned at the start of this
section and the research in the ﬁeld of genomics. It seems to be one of the
challenges of current research in nutrigenomics to develop dietary advice
that is not merely healthy at a population level, but is tailored to the genetic
make-up and particular circumstances of an individual, or of a sub-group
within a population (cf. Muller and Kersten, 2003; p. 319). These ‘‘per-
sonalized diets’’ or ‘‘tailor-made dietary advice’’ promises to be relevant
because of their ability to contribute to the cure of ailments, but also be-
cause of their contribution to preventive medicine. The knowledge of the
gene–diet interaction enables individuals to reduce a genetically induced
increased risk to a certain ailment by following speciﬁc dietary advice. With
the help of such a diet, one may prevent the emergence of the disease. Even
though this development is still in a research phase, some practical spin-oﬀs
have already been oﬀered to the public, mainly on the internet. The precise
applications for the future are not completely clear at this moment, yet it is
still considered as promising both as a part of a public approach to health
problems and as a more market-focused development in which companies
oﬀer dietary products or advice to particular groups (Meijboom, et al.,
2003).
In these three developments, we can recognize that the food sector and
health sector are becoming increasingly intertwined. This entails new roles
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and responsibilities for the involved professionals, institutions, and con-
sumers. This has a direct impact on trust. In order to substantiate this claim,
I ﬁrst elaborate on what we mean by trust.
3. TRUST: POSITIVE EXPECTATIONS
The concept of trust is too complex to take for granted. We are all familiar
with trust. Nevertheless trusting has very diﬀerent dimensions. Trusting the
national public health service is quite diﬀerent from trusting ones GP.
Entrusting the care for your health to someone else is perceived rather
diﬀerently than entrusting your computer problems to the ICT helpdesk.
Nevertheless, we talk about trust in all situations. It is this diversity that
Hardin has in mind when he writes, ‘‘the notion of trust in the vernacular is
often vaguely warm and fuzzy’’ (1999; p. 429). However, it is possible to say
something sensible about trust.
First, in all the above-mentioned situations, trust is a matter of dealing
with uncertainty and situations where individuals do not have control. It
enables us, for instance, to consume food even when we cannot control its
production process, or to use medicines even when we cannot assess their
safety. In these cases, we do not deliberately take a risk. Trust is not the
result of the assessment of hazard and change that can be approached with a
calculator on ones desk. In trusting, one acts ‘‘as if’’ certain possible state of
aﬀairs will not occur (Lewis and Weigert, 1985; Giddens, 1991). This does
not imply that one no longer runs a risk, but rather, that from the per-
spective of the trustor, one does not deliberately take a risk (cf. Lagerspetz,
1998). This acting ‘‘as if’’ is not an escape to a make-belief world of cer-
tainty. In the case of trust, one acts in spite of uncertainty, since one believes
one has good reasons for it. The trustor has certain positive expectations
towards the attitude and action of another. Thus, trust is a positive
expectation in cases of uncertainty and lack of control. However, we neither
have such expectations towards all others nor with regard to all issues.
This shows a second point: Trust is relational; it is often focused on
speciﬁc agents and is indexed to certain situations or a certain object of
trust. We do not trust everybody with everything. Normally we entrust
something to others when we consider it as valuable and important, but
beyond our control. Both are relevant, (a) if something can be determined
by a person, she does not need to trust it. For instance, to ﬁnd out the origin
of vegetables would not ask for trust when one grows ones own vegetables.
(b) If one considers something as (completely) irrelevant, there is also no
necessity to trust. For instance, when a consumer does not prefer to con-
sume ‘‘summer vegetables’’ all year round, he does not need to entrust the
TRUST, FOOD, AND HEALTH 235
safety and quality of lettuce in winter to other agents within the agri-food
chain, even though he cannot assess it himself. Furthermore, we do not have
positive expectations of all others with regard to a speciﬁc object. The an-
swer to the question of whom one trusts, depends also on two elements
(Baier, 1994). First, a trustee should be competent. Second, he or she should
show good will. Here again, both abilities and character are crucial. It is not
an either/or position. If someone certainly will show his good-will and re-
spond on my trust, but is completely incompetent as a physician, I will not
trust him regarding my health. The other way around, when some person is
one of the worlds most famous experts, but he obviously has a rather nasty
character, it still is quite unlikely that I will trust him. This is a problem that
companies and other market parties are often confronted with. They are
considered as having enough expertise to be trusted, but are not seen as
trustworthy, since one believes that they will not show any good-will, but
will only operate on the basis of their self-interest.
Hence, trust is a positive expectation towards competent and good-
willing others regarding issues one values in cases of uncertainty and lack of
control. This leads to the ﬁnal question: Why does one have such a positive
expectation in spite of the uncertainty?
4. REASONS FOR TRUST
Uncertainty can paralyze individuals and, in the end, even complete
sectors and societies. If one were to perceive consuming food or medicines
only from the perspective of all the risks one runs, but that one is unable
to assess oneself, consumption would be extremely problematic, if not
impossible. However, above I argued that trust is a way to act in spite of
this uncertainty and to go beyond this situation of paralysis. This acting
in spite of uncertainty is more than closing ones eyes to the risks one
runs. We have reasons to expect another to act in a speciﬁc way, although
we cannot control that person or institution. These reasons are in general
based upon (a) a certain level of predictability and/or (b) normative
considerations.
In the ﬁrst case we can speak about anticipatory trust (Sztompka, 1999)
or predictive trust (Hollis, 1998). These trust relationships are based upon
expectations regarding normal patterns and routines. When clear patterns
and routines are available, it is often easier to predict how the trusted person
will react and what to expect. This enables us to act even though we are
confronted with uncertainty and although we cannot control everything
involving others. For instance, if one has bought a product for many years,
one will expect that its safety and quality remain unchanged the next time
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one buys the product. Hence this person relies on this pattern even though
there is always a risk that this is the ﬁrst time the product is unsafe.
Additionally, there are situations in which we do not merely expect that
another will act in a certain way, but we expect something of another
(Hollis, 1998). These expectations are not grounded in actual routines, but
are based upon more profound beliefs about the way that the other agent
will be motivated, or should be motivated, to act in the expected way. For
instance, the presumption that reasonable human beings are essentially self-
regarding can be the basis for positive expectations when one is confronted
with uncertainty, but assesses that it is in anothers interest to act in the
expected way. This is not merely expecting that another will act according to
his self-interest, but one considers it as an important characteristic of rea-
sonable human beings and one expects it of another to be reasonable.
Moreover, expectations can be directly based upon moral beliefs. Some-
times, the trustor believes that another has a duty to react in a certain way
and that she is entitled to expect this. For instance, regarding government, I
do not only expect that they ensure an adequate clinical trial system in
introducing new medicines, I also expect it of them. I believe that they have
a moral duty to do so and that I am entitled to expect this. This duty does
not just depend on my trust, but helps me in trusting another. However,
there are also moral duties that are entailed by the act of trusting another.
This is what Løgstrup (1959) and Lagerspetz (1998) call the ‘‘tacit demand’’
of trust.3 When one entrusts something to the other, it entails an implicit
obligation to respond. For instance, a physician has a general duty to care
for her patients. This general moral belief can be enough reason for me to
trust her, yet because I entrusted her with my health problem, I consider her
to have also a speciﬁc obligation towards me in this situation. I expect her
not just to take care of the health of patients in general, but also to respond
to my speciﬁc health problem. The presumption that underlies this is that
the vulnerability of the trustor should not be abused by the trustee. For
instance, the ignorance and dependence of a consumer can never be a reason
to tamper with food safety, not even when no one would ever notice.
These diﬀerent reasons for the expectations that underlie trust are mixed
in practice. It is often a multilayered relation. For instance, when I trust my
supermarket with regard to the safety of the food on the shelves, I will
mainly expect that they will sell the same quality as normal. However,
beneath this level of the ‘‘expectation that’’ are my beliefs as to why they will
act in accordance to the normal pattern, e.g., because it is in the interest of
3 Scanlon suggests a similar idea by appealing to the ‘‘value of assurance.’’ This value
explains why it would be reasonable to reject principles that permit people (in the absence of
special justiﬁcation) not to fulﬁl the expectations they have deliberately raised in others (1998, p.
302–305).
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the company to sell safe food. Moreover, I think that they have a moral
obligation as a company to take their responsibility to prevent harm seri-
ously, and as a consequence, they have a moral duty to sell nothing but safe
food. Finally, the fact that I, as a consumer, have no option but to buy food
and thereby trust others entails a tacit demand that requires a response. As
long as my trust in food safety is unproblematic, all the underlying levels will
remain implicit and I will only expect that my food is safe. Baier rightly
compares trust to an atmosphere: we notice trust as we notice air, ‘‘only
when it becomes scare or polluted’’ (1994; p. 98). Hence, when there are
problems or scandals or when it is no longer clear what to expect, the other
levels become explicit.
5. A NEW RELATION AND THE IMPACT ON TRUST
Most trust in food products and health products is currently based upon the
predictability of the stakeholders. Routines and patterns are often clear
enough to act although one is confronted with uncertainty and lack of
personal control.4 There are long traditions and relatively clear norms that
give consumers clarity on what he can reasonably expect of others when he
buys a food or pharmaceutical product. However, we lack such clarity with
regard to the developments on the interface between food and health. To
discuss the impact this has on trust and what the consequences will be for
the involved agents, I follow the structure of the three developments in the
relationship between the food sector and the domain of health outlined
above.
5.1. Knowledge on the ‘‘Health–Diet’’ Interaction
The increasing knowledge of the ‘‘health–diet’’ interaction will have an eﬀect
on trust in three ways. First, it can show that, although one is not aware of
any risk or uncertainty, there certainly is a health risk. The information
entails that the consumer takes the step from ignorance to the awareness of
the involved risk. For instance, scientiﬁc evidence on the health risks
of consuming burned meat can show a consumer that the perceived safety of
barbequed meat is mainly based upon ignorance. Hence that consumer has
to reﬂect on whether he considers barbequing important and pleasant
enough to under take these health risks. In this example, a consumer can
make this deliberation himself, but even then, he has to trust the scientiﬁc
data and information that form the basis of his evaluation. This trust in
4 It is obvious that this does not hold for trust in biotechnology in food, or trust in the
immediate aftermath of serious food scandals.
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scientiﬁc information is mostly anticipatory trust. Since the information has
proved to be reliable many times in the past, it is trusted in this situation
again. This shows a second impact. The increasing knowledge sometimes
complicates anticipatory trust when scientists do not give a clear message on
what is healthy and what is not. For instance, eggs have been ‘‘not done’’ for
those with elevated levels of blood cholesterol for many years, while a
moderate consumption is now conceived as acceptable (Hu, et al., 1999).
This can result in a situation in which only the object of uncertainty changes
instead of trust being established. First, one is uncertain about what is
healthy, afterwards one is uncertain about which scientist to trust. This
shows the impact on a third level. As a result of the increasing knowledge on
the ‘‘health–diet’’ interaction, expectations changes towards those who are
involved in providing new information. Since most consumers cannot per-
sonally assess the available information, they have to trust scientists, dieti-
cians, physicians, or public health institutions. This implies that the
information should not only be scientiﬁcally sound, but also reckon with the
fact that individual consumers are in a dependent position in which they
often cannot but trust the experts, for instance by empowering them in order
to use this information. Here we recognize the tacit demand of trust, as has
been mentioned above. The fact that only trust in the involved agents turns
the newly obtained data into useful information, gives a special responsi-
bility to those agents that have the expertise to provide and assess the
information.
5.2. The Market Introduction of Functional Foods
Foods that have a special health value next to its nutritional value are high-
tech products that require trust in the expertise and good-will of a whole
range of agents. However, this need for trust is complicated by the level of
predictability, the clarity with regard to what we can expect of these prod-
ucts, but also by the vagueness regarding whom we can expect this from.
First, these new products will have an eﬀect on trust, since formulating
expectations based upon predictability can become diﬃcult. On the one
hand, we lack a clear pattern or routine, especially when new technologies,
e.g., biotechnology, are used in order to enhance the health eﬀects of food
products. A normal pattern as to how to deal with such technologies in food
is unavailable. It takes time before trust based upon routine is achievable.
Until that moment, trust can be vulnerable, since it is unclear what to expect
of the other party. On the other hand, issues of trust will arise as a result of
conﬂicting patterns. This can be explicated with the example of health
claims on the labels of food products. The idea of labels with special
information is not new. We have already been used to all kinds of labels and
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claims regarding food products, like ‘‘high fat,’’ ‘‘low sugar,’’ or ‘‘new
formula.’’ Regarding pharmaceutical products, we have a similar situation
in which the expectations concerning the instructions for use are clear. Yet
labels that inform you about the health enhancing aspects of food are new.
Consequently, it is not quite clear what to expect of them. We can consider
them as the usual food labels and adapt our expectations to what we nor-
mally expect of them, or we apply our expectations regarding the instruc-
tions for use of pharmaceutical products. This indistinctness can have a
direct inﬂuence on trust in food and pharmaceutical products. For instance,
when a label on a traditional product tells me that it is especially relevant for
elderly people, I still think that it is safe and unproblematic to use it even
when I do not belong to the target group. In the case of a pharmaceutical
product such an indication will alert me. Even when it is prescribed by my
GP, I will ask him whether this product is safe and eﬀective for me. Thus,
when a (imaginary) dairy product with a special hormone is introduced to
the market that has substantial health eﬀects for elderly consumers only, the
expectations I can reasonably formulate regarding this product are unclear.
In this situation, trust will become problematic, because there is no clear
routine that tells me what I can expect of this product. Moreover, it also
aﬀects my expectations with regard to other food and pharmaceutical
products, since I am no longer sure whether my ‘‘normal’’ expectations still
apply to those products. Some of these problems of trust may disappear
over time. Just as trust in trains was very low in the 19th Century, one can
argue that there will be enough predictability and clear routines in the future
to serve as foundation for our trust. However, above we have seen that trust
is not merely based upon predictability, but also on social and moral norms.
Therefore, trust in food products with health claims is not merely a matter
of getting used to a new situation.
Trust also requires clarity on what underlies the existing patterns, i.e.,
what one reasonably can expect of another in this new situation apart from
any routine or pattern. At this point the problem is not the lack of norms,
but the conﬂicts between them. For instance, for both the food sector and
health sector, safety is paramount in every introduction of a product.
Nevertheless, the speciﬁc interpretation of what safety means in relation to
pharmaceutical products is diﬀerent from food products. What we consider
as an acceptable safety standard regarding food is considered as insuﬃcient
for medicine and we accept side eﬀects of medication that we would never
accept in the case of food. These diﬀerences are not just the result of dif-
ferent customs, but are the result of reﬂection on what we consider as a
morally acceptable risk, given the aim of the product. This reﬂection can
explain why we will not accept the adverse eﬀects of medication for diabetes
from a slice of bread. The aim of treating diabetes is considered to be
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important enough to outweigh these problems, while we lack such an aim in
the case of bread. Such reﬂections – not only on safety, but also concerning
other issues like justice and autonomy – are necessary for trust in functional
foods.
Finally, functional foods show that the developments at the interface
between food and heath provide us with questions of whom we expect what.
Traditionally, health improvement has been a matter of physicians, phar-
macists, and other health professionals. Currently, other parties – mostly
market parties – have started to play an important role in this ﬁeld as well.
Since our expectations are both sector-dependent and agent-relative, this
shift has implications for trust. In many cases, we trust not merely someone
to do what we trust all others to do, but we require a speciﬁc action that we
can reasonably expect of that person. However, our expectations diﬀer from
stakeholder to stakeholder. What one expects of a supermarket is often
completely diﬀerent from what is expected from a pharmacy. For instance,
attention to taste and aesthetics is not something we expect of a pharma-
ceutical company, yet we trust food companies to pay a lot of attention to
taste and design before introducing a new product. Likewise, we do not
expect a greengrocer to ask every consumer that buys strawberries whether
he or she is allergic to them. For a physician this is quite diﬀerent. When he
knows that some medication can have adverse eﬀects for those who have
high blood pressure, we expect her to take account of this fact in prescribing
other medication. Normally, these diﬀerences are not very problematic as
far as it is clear whom one can expect to take care of the issues at stake.
However, it becomes more diﬃcult to determine what to expect of whom, if
a greengrocer were to sell vegetables claiming real health beneﬁts. The an-
swer to this question is crucial for trust in relation to functional foods.
5.3. Increasing Knowledge of the ‘‘Gene–Diet’’ Interaction
The combination of genetic and dietary knowledge that aims to develop
dietary advice tailored to ones genes equally raises questions of trust. First,
as in the case of the increasing knowledge of the food–health interaction, the
genetic knowledge can inform an individual of risks he runs of which he was
not aware. Personal diets are a kind of preventive medicine. They focus on
genetically induced increased levels of risk for a speciﬁc ailment. Hence, in
most situations, the involved persons have not noticed this risk at all. They
did not consider their health status in terms of trust until the information on
genetic risks alerts them. Therefore, the range of situations in which one has
to trust others will be extended.
Furthermore, the indications that it is likely that personalized diets
become a market instrument (cf. Meyer, 2005) rather than a tool for public
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health promotion, has an impact on ones expectations towards others.
Instead of scientists, the medical professionals, patients, and government as
the key agents, it seems that industry, scientists, consumers, and government
will be the central agents in this ﬁeld. Although we know what we can expect
of these agents in normal situations, it is not clear what can be expected of
them in respect of tailor-made, individual diets. Companies that provide
such advice oﬀer products that were up until now restricted to the medical
sector and oﬀer it in ways that are relatively new in relation to health. For
instance, the fact that many tests and much dietary advice is currently of-
fered via the internet presumes not only trust in the product, the company
that oﬀers it, but also in the proper functioning of the internet. Hence, even
when we know what we can expect of the involved others, we also need to
know what can be expected of the internet with regard to issues like the
conﬁdentiality of medical information. If I want to obtain the test and the
dietary advice, I have to trust that my personal information will not end up
in a database of other companies than the one that provides me with my
tailor-made diet. However, we do not only need to trust more persons and
institutions, we also have to entrust some stakeholders with new objects
when the dietary advice will be oﬀered in a market context. Trusting a
company to be competent and honorable in respect of the oﬀer of a genetic
test is for most of us something new. While there is enough precedence to
trust a physician to oﬀer a genetic test, for instance because he will oﬀer it if
and only if it is really necessary and beneﬁcial for the patient, it is not clear
what we can expect of industry. The market has other interests than merely
the interest of the consumers. They have shareholders, proﬁt margins, and
competitors that all need attention too. This is not something that makes
trust in them impossible, yet when genetic tests and personalized dietary
advice are oﬀered directly to customers, it should be clear what these indi-
viduals can expect of the company, but also what the company expects of its
customers.
6. INFORMATION AND PUBLIC DEBATE ON REASONABLE
EXPECTATIONS
In this article, I have shown that the combination of food and health not
only makes trust an even more crucial condition for consuming products,
but also raises some serious questions of trust. It is the case that not only
will our need to trust experts grow, but that the combination of two sectors
entails that existing patterns of trust are either unavailable or insuﬃciently
clear. Consequently it becomes more diﬃcult to base trust in predictability.
This implies that the development of attaching health aspects to food and
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dietary products should go hand in hand with adequate information and
enhancing transparency on procedures. It should be clear what standard
procedures are followed when functional foods or dietary advices are of-
fered. However, this is not merely a matter of good communication. It
suggests an underlying need for clarity as to why these procedures are re-
quired, e.g., why safety standards for food products are also applicable in
the case of functional foods.
This requires a profound debate to elucidate what can be expected of
new products and information, and of whom we can expect something
with regard to these products. To state that most health related food
products require trust in others is not a remarkable statement, yet to
identify these ‘‘others’’ is more diﬃcult. All involved agents will be con-
fronted with the fact that responsibilities will be combined together with
the combination of food and health. The current problem of this devel-
opment is that it is not obvious how responsibilities are, or should be
distributed in this context. Market parties, researchers, government, and
citizens all have responsibilities, however it is not clear beforehand who is
responsible for what and to what extent. For instance, consumers get more
and more opportunities to inﬂuence their own health status, both because
they get more information and because they are provided with more tools.
This can be the reason for other parties to expect that individuals are
responsible for and entrusted with, at least a part of the care of their
health. The question is whether this can reasonably be expected of indi-
viduals. That an individual is responsible for his own health is not really
open for discussion, but the above-mentioned issues suggest that the
reality may often be so complex that it becomes diﬃcult to just leave this
to the individual. Thus, it is not immediately clear to what extent other
stakeholders can expect the individual to be responsible. Likewise, market
parties are expected to reckon with the fact that introducing health-
enhancing products is more than just a new product innovation. Products
on the interface between food and health entail other expectations than
those associated with regular food products. However, can we expect of a
company that it lives up to all the expectations we normally have
regarding the medical sphere, since they introduced a margarine that
lowers ones blood cholesterol? Some will answer this question positively,
however, one can also argue that this is beyond what one can reasonably
be expected of a market party. This shows the importance of the role
government can play. Since both food and health are public goods, gov-
ernment intervention that regulates the ﬁeld between food and health
seems to be justiﬁed. This can be helpful with regard to those expectations
that remain unanswered. Government, for instance, can establish minimal
thresholds on safety, quality, and other preconditions for the production
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and consumption of new products. This at least provides clear standards
that hold for all involved parties on which expectations can be based. The
danger, however, is that all unsolved problems of expectation will end up
at the level of the government. Even if most problems of trust with regard
to the food-health relation have a public dimension, government cannot
take on all of the responsibilities that other agents are not prepared to
accept. If they were to do so, they cannot manage to live up to the
expectations and consequently cannot be trustworthy. Thus, even though
it seems reasonable to expect that there is clear regulation on issues like
safety, health claims, and other issues, government cannot ‘‘solve’’ the
issues of trust. This shows the need for a profound debate on responsi-
bilities and the explication and interpretation of moral values and norms.
Trust in the ﬁeld of food and health needs clarity as to what we can
reasonably expect of each other. This is not an easy discussion, yet it is a
necessity for trust that it can deal with situations of transition. Trust is
surely a precondition for utilizing the beneﬁts of the developments at the
interface between food and health.
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